Breast implant-associated, ALK-negative, T-cell, anaplastic, large-cell lymphoma: Establishment and characterization of a model cell line (TLBR-1) for this newly emerging clinical entity

Cancer

Volumn 117, Issue 7, 2011, Pages 1478-1489

  Lechner, Melissa G ^a   Lade, Stephen ^b   Liebertz, Daniel J ^a   Prince, H Miles ^b   Brody, Garry S ^a   Webster, Howard R ^b   Epstein, Alan L ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

anaplastic large cell lymphoma; breast implant; human cell line; Notch1; primary breast lymphoma

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; CD2 ANTIGEN; CD20 ANTIGEN; CD30 ANTIGEN; CD4 ANTIGEN; CD5 ANTIGEN; CD56 ANTIGEN; CD7 ANTIGEN; CD71 ANTIGEN; CD8 ANTIGEN; CYTOKERATIN; DIPEPTIDYL PEPTIDASE IV; EPITHELIAL MEMBRANE ANTIGEN; INTERLEUKIN 2; NOTCH1 RECEPTOR; PERFORIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; TUMOR MARKER;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BREAST AUGMENTATION; CANCER CELL; CANCER CELL CULTURE; CELL SHAPE; CELL STRAIN TLBR 1; CHROMOSOME ANALYSIS; CHROMOSOME NUMBER; CLONAL VARIATION; CONTROLLED STUDY; CYTOGENETICS; EPSTEIN BARR VIRUS; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN TISSUE; IMMUNOPEROXIDASE STAINING; IN SITU HYBRIDIZATION; LARGE CELL LYMPHOMA; LYMPHOCYTE SUBPOPULATION; MOUSE; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCID MOUSE; T CELL LYMPHOMA; TUMOR BIOPSY; WESTERN BLOTTING; XENOTRANSPLANTATION;

ADULT; ANIMALS; BREAST IMPLANTATION; BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, LARGE-CELL, ANAPLASTIC; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; PROTEIN-TYROSINE KINASES;

EID: 79952858725     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25654     Document Type: Article

References (27)

1. Bishara MR, Ross C, Sur M,. Primary anaplastic large cell lymphoma of the breast arising in reconstruction mammoplasty capsule of saline filled breast implant after radical mastectomy for breast cancer: an unusual case presentation. Diagn Pathol. 2009; 4: 11.
2. Newman MK, Zemmel NJ, Bandak AZ, Kaplan BJ,. Primary breast lymphoma in a patient with silicone breast implants: a case report and review of the literature. J Plast Reconstr Aesthet Surg. 2008; 61: 822-825. (Pubitemid 351970472)
3. Wong AK, Lopategui J, Clancy S, Kulber D, Bose S,. Anaplastic large cell lymphoma associated with a breast implant capsule: a case report and review of the literature. Am J Surg Pathol. 2008; 32: 1265-128.
4. Fritzsche FR, Pahl S, Petersen I, et al. Anaplastic large-cell non-Hodgkin′s lymphoma of the breast in periprosthetic localisation 32 years after treatment for primary breast cancer-a case report. Virchows Arch. 2006; 449: 561-564. (Pubitemid 44722325)
5. Sahoo S, Rosen PP, Feddersen RM, Viswanatha DS, Clark DA, Chadburn A,. Anaplastic large cell lymphoma arising in a silicone breast implant capsule: a case report and review of the literature. Arch Pathol Lab Med. 2003; 127: e115-8.
6. Roden AC, Macon WR, Keeney GL, Myers JL, Feldman AL, Dogan A,. Seroma-associated primary anaplastic large-cell lymphoma adjacent to breast implants: an indolent T-cell lymphoproliferative disorder. Mod Pathol. 2008; 21: 455-463. (Pubitemid 351441035)
7. de Jong D, Vasmel WL, de Boer JP, et al. Anaplastic large-cell lymphoma in women with breast implants. JAMA. 2008; 300: 2030-2035.
8. Lipworth L, Tarone RE, McLaughlin JK,. Breast implants and lymphoma risk: a review of the epidemiologic evidence through 2008. Plast Reconstr Surg. 2009; 123: 790-793.
9. Brody GS, Deapen D, Gill P, Epstein A, Martin S, Elatra W,. T cell non-Hodgkin′s anaplastic lymphoma associated with one style of breast implants. San Antonio, Texas: American Society of Plastic Surgeons Annual Conference, March 20-23, 2010. Scientific Session IX: Breast B, Oral communication and abstract 42.
10. Stein H, Mason DY, Gerdes J, et al. The expression of the Hodgkin′s disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood. 1985; 66: 848-858. (Pubitemid 15242469)
11. Kempf W,. CD30+ lymphoproliferative disorders: histopathology, differential diagnosis, new variants, and simulators. J Cutan Pathol. 2006; 33 (suppl 1): 58-70.
12. Rosen ST, Querfeld C,. Primary cutaneous T-cell lymphomas. Hematology Am Soc Hematol Educ Program. 2006: 323-30.
13. Falini B, Martelli MP,. Anaplastic large cell lymphoma: changes in the World Health Organization classification and perspectives for targeted therapy. Haematologica. 2009; 94: 897-900.
14. Querfeld C, Kuzel TM, Guitart J, Rosen ST,. Primary cutaneous CD30+ lymphoproliferative disorders: new insights into biology and therapy. Oncology. 2007; 21: 689-700.
15. Lamant L, Espinos E, Duplantier M, et al. Establishment of a novel anaplastic large-cell lymphoma-cell line (COST) from a ′small-cell variant′ of ALCL. Leukemia. 2004; 18: 1693-1698. (Pubitemid 39386349)
16. Juco J, Holden JT, Mann KP, Kelley LG, Li S,. Immunophenotypic analysis of anaplastic large cell lymphoma by flow cytometry. Am J Clin Pathol. 2003; 119: 205-212. (Pubitemid 37047875)
17. Herbst, H, Drexler, HG,. CD30-Positive Anaplastic Large Cell Lymphoma Cell Lines. In:, JRW Masters, Palsson BO, eds. Human Cell Culture: Cancer Cell Lines, pt 3: Leukemias and Lymphomas. Vol 3. Netherlands: Springer; 2000: 355-370.
18. Theriault C, Galoin S, Valmary S, et al. PCR analysis of immunoglobulin heavy chain (IgH) and TcR-gamma chain gene rearrangements in the diagnosis of lymphoproliferative disorders: results of a study of 525 cases. Mod Pathol. 2000; 13: 1269-1279. (Pubitemid 32014663)
19. Ferrando AA, Look AT,. Gene expression profiling in T-cell acute lymphoblastic leukemia. Semin Hematol. 2003; 40: 274-280. (Pubitemid 37296777)
20. Jundt F, Anagnostopoulos I, Forster R, Mathas S, Stein H, Dorken B,. Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma. Blood. 2002; 99: 3398-3403. (Pubitemid 34525322)
21. Epstein AL, Kaplan HS,. Feeder layer and nutritional requirements for the establishment and cloning of human malignant lymphoma cell lines. Cancer Res. 1979; 39: 1748-1759. (Pubitemid 9171837)
22. Venard V, Carret AS, Pascal N, Rihn B, Bordigoni P, Le Faou A,. A convenient semi-quantitative method for the diagnosis of Epstein-Barr virus reactivation. Arch Virol. 2000; 145: 2211-2216.
23. Pawson R, Schulz TF, Matutes E, Catovsky D,. The human T-cell lymphotropic viruses types I/II are not involved in T prolymphocytic leukemia and large granular lymphocytic leukemia. Leukemia. 1997; 11: 1305-1311. (Pubitemid 27387308)
24. Cui W, Taub DD, Gardner K,. qPrimerDepot: a primer database for quantitative real time PCR. Nucleic Acids Res. 2007; 35: D805-D809. (Pubitemid 46056313)
25. Drexler HG,. The Leukemia-Lymphoma Cell Line Facts Book. San Diego: Academic Press; 2001: 487-503.
26. Turbat-Herrera EA, Veillon D, Cotelingam J, Fowler M, Herrera GA,. The ultrastructural and immunohistochemical heterogeneity of CD30-positive neoplasms: so-called anaplastic large cell Ki-1 lymphomas. Med Electron Microsc. 2001; 34: 19-28.
27. Allenspach EJ, Maillard I, Aster JC, Pear WS,. Notch signaling in cancer. Cancer Biol Ther. 2002; 1: 466-476.